Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mueller

Showing results (1331-1340 of 1,673) with videos related to

Pageof 168
Sort By:
Gynecologic Oncology|February 24, 2021
Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancerArnaud Da Cruz Paula, Deborah F DeLair, Lorenzo Ferrando, et al.
Gynecologic Oncology|October 17, 2022
Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic driversSarah Ehmann, Dib Sassine, Alli M Straubhar, et al.
Psychiatria Danubina|July 11, 2019
Integration of complementary biomarkers in patients with first episode psychosis: research protocol of a prospective follow up studyMartina Rojnic Kuzman, Porin Makaric, Dina Bosnjak Kuharic, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002
Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomasO M Sieber, H Lamlum, M D Crabtree, et al.
JCO Precision Oncology|January 29, 2026
Age-Related Germline Landscape of Endometrial Cancer: Focus on Early-Onset CasesJudy J Wang, Juliet Milani, Sarah Kane, et al.
Trials|October 22, 2021
A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®Benjamin Speich, Frédérique Chammartin, Daniel Smith, et al.
American Journal of Obstetrics and Gynecology|December 13, 2021
Risk factors for financial toxicity in patients with gynecologic cancerEmeline M Aviki, Beryl L Manning-Geist, Stefania S Sokolowski, et al.
Plos One|January 24, 2025
Low agreement and frequent invalid controls in two SARS-CoV-2 T-cell assays in people with compromised immune functionAnnette Audigé, Alain Amstutz, Macé M Schuurmans, et al.
Open Forum Infectious Diseases|April 10, 2023
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2)Alexandra Griessbach, Frédérique Chammartin, Irene A Abela, et al.
NPJ Digital Medicine|October 29, 2024
A digital, decentralized trial of exercise therapy in patients with cancerWhitney P Underwood, Meghan G Michalski, Catherine P Lee, et al.
Pageof 168

Showing results (1331-1340 of 1,673) with videos related to

Sort By:
Pageof 168
Gynecologic Oncology|February 24, 2021
Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancerArnaud Da Cruz Paula, Deborah F DeLair, Lorenzo Ferrando, et al.
Gynecologic Oncology|October 17, 2022
Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic driversSarah Ehmann, Dib Sassine, Alli M Straubhar, et al.
Psychiatria Danubina|July 11, 2019
Integration of complementary biomarkers in patients with first episode psychosis: research protocol of a prospective follow up studyMartina Rojnic Kuzman, Porin Makaric, Dina Bosnjak Kuharic, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002
Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomasO M Sieber, H Lamlum, M D Crabtree, et al.
JCO Precision Oncology|January 29, 2026
Age-Related Germline Landscape of Endometrial Cancer: Focus on Early-Onset CasesJudy J Wang, Juliet Milani, Sarah Kane, et al.
Trials|October 22, 2021
A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®Benjamin Speich, Frédérique Chammartin, Daniel Smith, et al.
American Journal of Obstetrics and Gynecology|December 13, 2021
Risk factors for financial toxicity in patients with gynecologic cancerEmeline M Aviki, Beryl L Manning-Geist, Stefania S Sokolowski, et al.
Plos One|January 24, 2025
Low agreement and frequent invalid controls in two SARS-CoV-2 T-cell assays in people with compromised immune functionAnnette Audigé, Alain Amstutz, Macé M Schuurmans, et al.
Open Forum Infectious Diseases|April 10, 2023
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2)Alexandra Griessbach, Frédérique Chammartin, Irene A Abela, et al.
NPJ Digital Medicine|October 29, 2024
A digital, decentralized trial of exercise therapy in patients with cancerWhitney P Underwood, Meghan G Michalski, Catherine P Lee, et al.
Pageof 168